Skip to content

克雷苏德

US · CRESY #3395 按市值排名
11.52 +0.13 +1.14%
实时 - 追踪5344个代码 - 心跳于348秒前 · 2026-10-16 19:30

估值 各估值倍数与自身5年区间的对比

市净率 0.86 处于历史正常水平 第51百分位
5年平均 0.85 · 在Conglomerates中排名第9/26
市盈率 6.54 高于历史水平 第70百分位
5年平均 2.77 · 前瞻 8.79 · 在Conglomerates中排名第4/14
市销率 0.91 低于历史水平 第30百分位
5年平均 1.23 · 前瞻 0.79 · 在Conglomerates中排名第17/29

同业对比 Conglomerates

公司 市值 市盈率(TTM) 市净率 股息率
克雷苏德 (CRESY) 817.06M 6.46 0.85 5.32%
3M (MMM) 84.97B 29.26 28.78 1.83%
Honeywell (HON) 67.00B 8.20 3.61 4.45%
Valmont Industries (VMI) 8.58B 17.36 4.97 0.65%
Brookfield Business Corp (BBUC) 5.45B -61.67 1.01 0.94%
Graham Holdings (GHC) 5.10B 9.73 1.07 0.61%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★★★ 合理价值15.18 经济护城河None 不确定性High

当前股价低于晨星合理价值估算31.8%。

合理价值

Cresud SACIF y A is assigned a 5-star quantitative star rating, reflecting our opinion that this share class offers a compelling opportunity for investors. The stock currently trades at a 23% discount to our quantitative fair value estimate of $15.18 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's valuation metrics increase our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 112.2%, which lies in the top 30% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The company's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 4.1, for example, ranks in the bottom 30% compared with global peers. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.

经济护城河

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

作者:Quantitative Equity Report

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

克雷苏德 讨论区 0 条评论

发表评论